Your browser doesn't support javascript.
loading
Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.
Ozmert, Emin; Arslan, Umut.
Affiliation
  • Ozmert E; Ankara University Faculty of Medicine, Department of Ophthalmology, Ankara, Türkiye.
  • Arslan U; Ankara University Technopolis, Bioretina Eye Clinic, AnkaraTürkiye.
Stem Cells Transl Med ; 12(10): 631-650, 2023 10 05.
Article in En | MEDLINE | ID: mdl-37713598

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinitis Pigmentosa / Wharton Jelly / Mesenchymal Stem Cells Limits: Humans Language: En Journal: Stem Cells Transl Med Year: 2023 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinitis Pigmentosa / Wharton Jelly / Mesenchymal Stem Cells Limits: Humans Language: En Journal: Stem Cells Transl Med Year: 2023 Document type: Article Country of publication: United kingdom